Single award · contract

COVID-19 Adult MDV Vaccine

Award ID: W58P0522C0016

FY2022 · complete year · data as of 2026-07-11

A single federal award, with both ends of the trail linked.

$4B
Total award value

Award W58P0522C0016 is a contract from the Department of Defense to Pfizer Inc, $4B obligated, FY2022 to FY2024, for COVID-19 Adult MDV Vaccine. The work is performed in New York. It is classified as NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and Biologicals). Source

Agency ›
Department of Defense
Source
awarded→$4B
Recipient ›
Pfizer Inc
Source
performed in→
State ›
New York
Source

Award details

Award typeContract
PIIDW58P0522C0016
Action date2022
Period20 mo
Awarding agencyDepartment of Defense →
RecipientPfizer Inc →
Place of performanceNew York →
CategoryNAICS 325412PSC 6505
Competed?Not recordedSource
Total (exact)$4,038,717,532

More awards to Pfizer Inc

Award of 10M Treatment Courses of Oral Protease Inhibitor PF-07321332
awarded 2021$12.5B
COVID-19 Vaccine Production
awarded 2020$11.1B
COVID-19 Vaccines for International Donation
awarded 2021$4.2B
Vaccine for Children (VFC) 2014
awarded 2014$1B
2017 Vaccines for Children
awarded 2017$1B
All awards to this recipient →

More from Department of Defense

Contract HT940216C0001
awarded 2016$51.3B
SSN 802 and 803 Long Lead Time Material
awarded 2017$35.7B
LRIP Lot 12 Advance Acquisition Contract
awarded 2017$35.1B
Contract N0001902C3002
awarded 2001$34.2B
KC-X Modernization Program
awarded 2011$32B
All awards from this agency →
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.